p: +61 (0)3 9594 4395
Senior Principal Research Fellow, NHMRC
Honorary Professor, Department of Obstetrics & Gynaecology, Monash University
Honorary Professor, Department of Obstetrics & Gynaecology, The University of Melbourne
Director of Research, Royal Women's Hospital, Melbourne
Jock Findlay joined PHI in 1979 and leads the Ovarian Biology Laboratory. Jock has published over 350 research papers and received multiple awards and accolades for his work.
A major theme of his research has been in understanding how fertility in women is related to the function of their ovaries, exploring how healthy eggs are formed, stored and released.
His research has led to a shift in understanding how hormones have local effects on the body including the production of eggs. Jock’s work has also contributed to the development of improved IVF procedures and understanding of fertility and infertility.
Female fertility and infertility, ovarian physiology, uterine biology, implantation
2009 - Life Member of Society for Reproductive Biology
2008 - Made an Officer of the Order of Australia (AO)
2006 - Awarded the Dale Medal by the UK Society for Endocrinology
2006 - Distinguished Scientist Award made by the UK Society for Reproduction & Fertility
1999 - Awarded the Asia & Oceania Medal of the UK Society for Endocrinology
Service to the Scientific Community
2003 - 2009 Chair, NHMRC Embryo Research Licensing Committee
2003-2009 Member, NHMRC Council
2003-2009 Chair, Infertility Treatment Authority, Victoria
Member and Chair, Bio21 Scientific Advisory Committee
Member, Board, Bio21 Cluster
Member, Bio21 Hospital Research Directors Committee
Director, Society for the Study of Reproduction, USA
Co-Director, Ovarian Workshop, USA
Member, Board, Victorian Breast Cancer Research Consortium
Chair, Scientific Committee, Victorian Breast Cancer Research Consortium
Member, Melbourne Health Biobank Management Committee
- Member, Board, Robinson Institute, University of Adelaide
Escalona RM, Stenvers KL, Farnworth PG, Findlay JK, and Ooi GT (2009) Reducing Betaglycan Expression by RNA interference (RNAi) Attenuates Inhibin Bio-Activity in LβT2 Gonadotropes.
Mol Cell Endocrinol.doi:10:1016/j.mce.2009.03.021. In press.
Bilandzic M, Chu S, Farnworth P, Harrison CA, Nicholls P, Wang Y, Escalona RM, Fuller PJ, Findlay JK, and Stenvers KL Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells. Mol Endocrinol. 23(4): 539-548, 2009.
Rosairo D, Kuyznierewicz I, Findlay J, Drummond A. TGF-beta: its role in ovarian follicle development. Reproduction. 136(6): 799-809, 2008.
Drummond AE, Tellbach, M., Dyson, M. Findlay JK, Fibroblast growth factor 9, a male sex determining factor identified in the ovary. Endocrinology, 148, 3711-3721, 2007.
Farnworth PG, Wang Y, Escalona R, Leembruggen P, Ooi GT, Findlay JK Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan. Endocrinology 148: 5355-5368, 2007.
Kerr JB, Duckett R, Britt KL, Mladenovska T, Myers M and Findlay JK. Quantification of healthy follicles in the neonatal and adult mouse ovary. Reproduction 132, 95-109, 2006.
Farnworth PG, Stanton PG, Wang Y, Escalona R, Findlay JK and Ooi GT. Inhibins differentially antagonize activin and bone morphogenetic protein (BMP) action in a mouse adrenocortical cell line. Endocrinology 147, 3462-3471, 2006.
Findlay JK, Gear ML, Illingworth PJ, Junk SM, Kay G, Mackerras AH, Pope A, Rothenfluh HS and Wilton L. Human embryo - a biological definition. Human Reproduction 10, 1093, 2006.